BeiGene, Ltd. (HKG:6160)
152.20
+0.70 (0.46%)
Apr 24, 2025, 4:08 PM HKT
BeiGene Employees
BeiGene had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
2.69M HKD
Profits / Employee
-455.31K HKD
Market Cap
208.76B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Innovent Biologics | 5,659 |
Akeso | 3,035 |
Alibaba Health Information Technology | 1,435 |
Sino Biopharmaceutical | 24,379 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,477 |
BeiGene News
- 20 days ago - BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit - Benzinga
- 20 days ago - BeiGene slips on decision to halt lung cancer program - Seeking Alpha
- 23 days ago - BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer - Business Wire
- 7 weeks ago - China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer - Benzinga
- 7 weeks ago - BeiGene wins FDA nod for Tevimbra in first-line esophageal cancer - Seeking Alpha
- 7 weeks ago - BeiGene: Q4 Results Impress With Positive Earnings Expected In 2025 - Seeking Alpha
- 7 weeks ago - Q4 2024 Beigene Ltd Earnings Presentation Transcript - GuruFocus
- 7 weeks ago - BeiGene, Ltd. (ONC) Q4 2024 Earnings Call Transcript - Seeking Alpha